P2Y12 Platelet Inhibitor [EPC]

23563 reported adverse events

Drugs of this class: TICAGRELOR CANGRELOR

These side effects are most commonly reported by patients taking drugs of the P2Y12 Platelet Inhibitor [EPC] class:

#	Side effect	Count
0	DYSPNOEA	3222
1	MYOCARDIAL INFARCTION	2088
2	OFF LABEL USE	1326
3	CHEST PAIN	1227
4	FATIGUE	1213
5	DEATH	1100
6	DIZZINESS	974
7	CONTUSION	931
8	MALAISE	769
9	HAEMORRHAGE	749

See all common reactions for P2Y12 Platelet Inhibitor [EPC]

Drugs of the P2Y12 Platelet Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

#	Side effect	Count	Frequency
0	VASCULAR STENT OCCLUSION	145	0.4739
1	DIABETIC MACROANGIOPATHY	12	0.4138
2	VASCULAR STENT THROMBOSIS	609	0.3833
3	VASCULAR STENT RESTENOSIS	28	0.2979
4	VASCULAR STENT STENOSIS	68	0.2720
5	ARTERIAL RESTENOSIS	19	0.1624
6	PLATELET AGGREGATION INHIBITION	10	0.1351
7	VENTRICULAR ASYSTOLE	18	0.1277
8	THROMBOSIS IN DEVICE	335	0.1091
9	STENT MALFUNCTION	18	0.1084

See all enriched reactions for P2Y12 Platelet Inhibitor [EPC]